Literature DB >> 14557011

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles.

Ernest H Y Ng1, Benyu Miao, Wai Cheung, Pak-Chung Ho.   

Abstract

OBJECTIVE: To compare side effects and patient inconvenience of two vaginal progesterone (P) formulations for luteal support in in vitro fertilisation cycles. STUDY
DESIGN: Sixty infertile patients at risk of developing ovarian hyperstimulation syndrome were randomised to receive either Cyclogest vaginal suppositories 400mg twice daily or Crinone 8% vaginal gel once daily for 14 days as the luteal support. On Day 6 and Day 16 after embryo transfer, they rated side effects and patient inconvenience into four grades: none, mild, moderate and severe by completing a questionnaire.
RESULTS: Perineal irritation was reported by about 20% of patients in each group. Significantly more patients using Cyclogest suppositories graded inconvenience of administration, leaking out and interference with coitus as moderate or severe.
CONCLUSION: There was no difference in perineal irritation after Cyclogest suppositories or Crinone 8% gel although significantly more patients found inconvenience of administration, leaking out and interference with coitus after Cyclogest.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557011     DOI: 10.1016/s0301-2115(03)00156-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

Review 1.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

2.  Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support.

Authors:  Funda Satir; Tayfun Toptas; Murat Inel; Munire Erman-Akar; Omur Taskin
Journal:  Exp Ther Med       Date:  2013-04-04       Impact factor: 2.447

3.  A questionnaire-based audit to assess overall experience and convenience among patients using vaginal progesterone tablets (Lutigest®) for luteal phase support during IVF treatment.

Authors:  Polly Heine; Laura Sellar; Sue Whitten; Priti Bajaj
Journal:  Patient Relat Outcome Meas       Date:  2017-12-08

4.  Progesterone for Luteal Phase Support in In Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study.

Authors:  Mohamed Khrouf; Soufiene Slimani; Myriam Razgallah Khrouf; Marouen Braham; Maha Bouyahia; Khadija Kacem Berjeb; Hanene Elloumi Chaabane; Ghaya Merdassi; Aida Zahaf Kaffel; Amel Zhioua; Fethi Zhioua
Journal:  Clin Med Insights Womens Health       Date:  2017-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.